[1] Miller JB, Figueroa EJ, Haug RM, et al. Thrombocytopenia in Chronic Liver Disease and the Role of Thrombopoietin Agonists. Gastroenterol Hepatol (N Y), 2019, 15(6):326-332. [2] Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol, 2017, 14;23(18):3228-3239. [3] Markus Trieb,Florian Rainer,Vanessa Stadlbauer, et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J Hepatol, 2020, 73(1):113-120. [4] Estcourt LJ. Thrombocytopenia in Surgery and Neuraxial Anesthesia. Semin Thromb Hemost, 2020, 46(3):245-255. [5] Kim H, Suh KS, Jeon YM, et al. Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation. Transplant Proc, 2012, 44(3):755-6. [6] Nicolau-Raducu R, Beduschi T, Vianna R, et al. Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation. Liver Transpl, 2019, 25(3):380-387. [7] Amygdalos I, Czigany Z, Bednarsch J, et al. Low Postoperative Platelet Counts Are Associated with Major Morbidity and Inferior Survival in Adult Recipients of Orthotopic Liver Transplantation. J Gastrointest Surg, 2020, 24(9):1996-2007. [8] Nobuoka Y, Wada H, Mizuno S, et al. Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function. Int J Hematol,2014, 99(4):418-28. [9] Jarmulski W, Wieczorkowska A, Trzaska M, et al. Platelets level variability during the first year after liver transplantation in the risk prediction model for recipients mortality. Ann Hepatol, 2020, 19(4):417-421. [10] Kusakabe J, Hata K, Tanaka S, et al. Prognostic index consisting of early post-transplant variables <2 weeks in adult living-donor liver transplantation. Hepatol Res,2020, 50(6):741-753. [11] Nickkholgh A, Wang J, Shahbazov R, et al. Intervention on Spontaneous Splenorenal Shunt May Decrease the Incidence of Acute Kidney Injury After Liver Transplant. Exp Clin Transplant,2020, 18(3):320-324. [12] Magwenzi S, Woodward C, Wraith KS, et al. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood,2015,125(17):2693-703. [13] Bhat A, Das S, Yadav G, et al. Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis. Hepatol Commun, 2019, 23;4(1):50-65. |